Navellier & Associates Inc. bought a new position in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 146,048 shares of the company's stock, valued at approximately $10,185,000. BrightSpring Health Services makes up about 0.8% of Navellier & Associates Inc.'s holdings, making the stock its 27th biggest holding. Navellier & Associates Inc. owned approximately 0.07% of BrightSpring Health Services at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of BTSG. Allworth Financial LP purchased a new position in BrightSpring Health Services during the second quarter valued at $28,000. NBC Securities Inc. bought a new position in shares of BrightSpring Health Services during the 4th quarter valued at about $29,000. GHP Investment Advisors Inc. bought a new position in shares of BrightSpring Health Services during the 1st quarter valued at about $31,000. EverSource Wealth Advisors LLC bought a new position in shares of BrightSpring Health Services during the 2nd quarter valued at about $43,000. Finally, Kilter Group LLC purchased a new position in shares of BrightSpring Health Services during the second quarter valued at about $50,000.
Insider Buying and Selling at BrightSpring Health Services
In related news, insider Lisa A. Nalley sold 35,000 shares of the firm's stock in a transaction on Friday, June 5th. The stock was sold at an average price of $58.75, for a total value of $2,056,250.00. Following the completion of the sale, the insider directly owned 131,948 shares in the company, valued at $7,751,945. This trade represents a 20.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jon B. Rousseau sold 130,000 shares of the firm's stock in a transaction on Friday, June 5th. The stock was sold at an average price of $58.75, for a total value of $7,637,500.00. Following the completion of the sale, the insider owned 1,194,503 shares of the company's stock, valued at approximately $70,177,051.25. This represents a 9.82% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 2.80% of the company's stock.
BrightSpring Health Services Trading Down 2.9%
BTSG opened at $59.13 on Friday. The stock has a 50-day moving average of $65.91 and a 200 day moving average of $54.81. The company has a current ratio of 1.59, a quick ratio of 1.22 and a debt-to-equity ratio of 1.06. BrightSpring Health Services, Inc. has a 12 month low of $22.86 and a 12 month high of $73.75. The firm has a market cap of $11.70 billion, a P/E ratio of 35.62, a P/E/G ratio of 0.73 and a beta of 1.88.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.05. The business had revenue of $3.87 billion for the quarter, compared to the consensus estimate of $3.66 billion. BrightSpring Health Services had a return on equity of 16.73% and a net margin of 2.55%.The company's quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.22 earnings per share. As a group, research analysts forecast that BrightSpring Health Services, Inc. will post 1.82 EPS for the current year.
Analyst Upgrades and Downgrades
BTSG has been the topic of a number of research analyst reports. BTIG Research reiterated a "buy" rating and issued a $90.00 target price on shares of BrightSpring Health Services in a research report on Thursday, August 13th. Weiss Ratings restated a "buy (b-)" rating on shares of BrightSpring Health Services in a report on Friday, July 31st. TD Cowen lifted their price objective on BrightSpring Health Services from $65.00 to $81.00 and gave the stock a "buy" rating in a research note on Thursday, June 18th. Morgan Stanley lifted their price objective on BrightSpring Health Services from $71.00 to $80.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 14th. Finally, Zacks Research raised BrightSpring Health Services from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 4th. Two research analysts have rated the stock with a Strong Buy rating and eighteen have given a Buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $70.71.
Get Our Latest Report on BrightSpring Health Services
BrightSpring Health Services Company Profile
(
Free Report)
BrightSpring Health Services NASDAQ: BTSG is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company's operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.
Through its network of subsidiary brands, BrightSpring offers integrated care in the patient's home environment, fostering independence and improving quality of life.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.